205 related articles for article (PubMed ID: 22802145)
1. Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells.
Blagosklonny MV
Oncotarget; 2012 Jun; 3(6):601-7. PubMed ID: 22802145
[TBL] [Abstract][Full Text] [Related]
2. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.
Jackson JG; Pant V; Li Q; Chang LL; Quintás-Cardama A; Garza D; Tavana O; Yang P; Manshouri T; Li Y; El-Naggar AK; Lozano G
Cancer Cell; 2012 Jun; 21(6):793-806. PubMed ID: 22698404
[TBL] [Abstract][Full Text] [Related]
3. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.
Lebedeva S; Bagdasarova S; Tyler T; Mu X; Wilson DR; Gjerset RA
Hum Gene Ther; 2001 May; 12(7):763-72. PubMed ID: 11339893
[TBL] [Abstract][Full Text] [Related]
5. INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Mason KA; Valdecanas D; Hunter NR; Milas L
Invest New Drugs; 2008 Feb; 26(1):1-5. PubMed ID: 17628743
[TBL] [Abstract][Full Text] [Related]
6. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.
Tikoo K; Sane MS; Gupta C
Toxicol Appl Pharmacol; 2011 Mar; 251(3):191-200. PubMed ID: 21194538
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors.
Bearss DJ; Subler MA; Hundley JE; Troyer DA; Salinas RA; Windle JJ
Oncogene; 2000 Feb; 19(8):1114-22. PubMed ID: 10713698
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo.
Koblish HK; Zhao S; Franks CF; Donatelli RR; Tominovich RM; LaFrance LV; Leonard KA; Gushue JM; Parks DJ; Calvo RR; Milkiewicz KL; Marugán JJ; Raboisson P; Cummings MD; Grasberger BL; Johnson DL; Lu T; Molloy CJ; Maroney AC
Mol Cancer Ther; 2006 Jan; 5(1):160-9. PubMed ID: 16432175
[TBL] [Abstract][Full Text] [Related]
10. P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis.
Fuchs-Young R; Shirley SH; Lambertz I; Colby JK; Tian J; Johnston D; Gimenez-Conti IB; Donehower LA; Conti CJ; Hursting SD
Breast Cancer Res Treat; 2011 Nov; 130(2):399-408. PubMed ID: 21191649
[TBL] [Abstract][Full Text] [Related]
11. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.
Zhan M; Yu D; Lang A; Li L; Pollock RE
Cancer; 2001 Sep; 92(6):1556-66. PubMed ID: 11745235
[TBL] [Abstract][Full Text] [Related]
12. α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation.
Shibata MA; Iinuma M; Morimoto J; Kurose H; Akamatsu K; Okuno Y; Akao Y; Otsuki Y
BMC Med; 2011 Jun; 9():69. PubMed ID: 21639868
[TBL] [Abstract][Full Text] [Related]
13. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.
Jabbour-Leung NA; Chen X; Bui T; Jiang Y; Yang D; Vijayaraghavan S; McArthur MJ; Hunt KK; Keyomarsi K
Mol Cancer Ther; 2016 Apr; 15(4):593-607. PubMed ID: 26826118
[TBL] [Abstract][Full Text] [Related]
14. Metabolic history impacts mammary tumor epithelial hierarchy and early drug response in mice.
Montales MT; Melnyk SB; Liu SJ; Simmen FA; Liu YL; Simmen RC
Endocr Relat Cancer; 2016 Sep; 23(9):677-90. PubMed ID: 27402613
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin.
Hay T; Matthews JR; Pietzka L; Lau A; Cranston A; Nygren AO; Douglas-Jones A; Smith GC; Martin NM; O'Connor M; Clarke AR
Cancer Res; 2009 May; 69(9):3850-5. PubMed ID: 19383921
[TBL] [Abstract][Full Text] [Related]
16. Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment.
Chung SW; Kim GC; Kweon S; Lee H; Choi JU; Mahmud F; Chang HW; Kim JW; Son WC; Kim SY; Byun Y
Biomaterials; 2018 Nov; 182():35-43. PubMed ID: 30103170
[TBL] [Abstract][Full Text] [Related]
17. Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function.
Margalit O; Simon AJ; Yakubov E; Puca R; Yosepovich A; Avivi C; Jacob-Hirsch J; Gelernter I; Harmelin A; Barshack I; Rechavi G; D'Orazi G; Givol D; Amariglio N
Int J Cancer; 2012 Aug; 131(4):E562-8. PubMed ID: 21932419
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
[TBL] [Abstract][Full Text] [Related]
19. The gain of function of p53 cancer mutant in promoting mammary tumorigenesis.
Lu X; Liu DP; Xu Y
Oncogene; 2013 Jun; 32(23):2900-6. PubMed ID: 22824795
[TBL] [Abstract][Full Text] [Related]
20. P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells.
Vayssade M; Haddada H; Faridoni-Laurens L; Tourpin S; Valent A; Bénard J; Ahomadegbe JC
Int J Cancer; 2005 Oct; 116(6):860-9. PubMed ID: 15849742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
